While Irisin has been found to activate the p38 and ERK signaling pathways, thereby promoting the proliferation and differentiation of osteoblasts in vitro, its role in regulating bone modeling and whether it can tip the balance towards bone formation under conditions such as osteoporosis or fracture remains a topic of debate. This evidence concerns the gene MAPK1 and osteoporosis.